Activated FGF2 signaling pathway in tumor vasculature is essential for acquired resistance to anti-VEGF therapy
Crossref DOI link: https://doi.org/10.1038/s41598-020-59853-z
Published Online: 2020-02-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ichikawa, Kenji
Watanabe Miyano, Saori
Minoshima, Yukinori
Matsui, Junji
Funahashi, Yasuhiro
Text and Data Mining valid from 2020-02-19
Version of Record valid from 2020-02-19
Article History
Received: 22 May 2019
Accepted: 21 January 2020
First Online: 19 February 2020
Competing interests
: All authors are employees of Eisai.